ITCI

Intra Cellular Therapies Stock Price

24.87
-1.23 (-4.71%)
Upgrade to Real-Time
Regular Market
24.87
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Intra Cellular Therapies Inc ITCI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.23 -4.71% 24.87 11:58:07
Close Price Low Price High Price Open Price Previous Close
24.62 26.15 25.74 26.10
Bid Price Ask Price Spread News
24.85 24.91 0.06 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,357 254,044 $ 25.26 $ 6,417,515 1,177,697 8.51 - 43.56
Last Trade Time Type Quantity Stock Price Currency
11:58:45 26 $ 24.87 USD

Intra Cellular Therapies Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.96B 78.97M 70.34M $ 60.61k $ - -2.68 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Intra Cellular Therapies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ITCI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week26.5226.9124.6225.64690,081-1.65-6.22%
1 Month27.0127.6123.7525.62819,988-2.14-7.92%
3 Months19.9642.9917.2628.391,929,7514.9124.6%
6 Months17.8942.9916.1426.431,346,9636.9839.02%
1 Year8.7643.568.5125.971,607,42016.11183.9%
3 Years15.7943.566.7521.32893,3619.0857.5%
5 Years47.1159.966.7521.68784,485-22.24-47.21%

Intra Cellular Therapies Description

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.